Related Experiment Video
Updated: Jun 5, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
New developments in antihypertensive drugs
1Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin 2, Ireland.
Abstract:
New developments in antihypertensive drug treatment include optimizing the use of established drugs, the introduction of novel compounds, and a renewed appreciation that hypertension is but one of various cardiovascular risk factors that must be addressed in managing the patient with raised blood pressure. Thus, the approach used must be tailored to the individual patient both in terms of drug choice and dose as well as preventive measures. New drug development depends very much on improving our understanding of the pathophysiologic mechanisms involved in hypertension and seems likely to be applied at the level of the renin angiotensin system and other local factors governing vascular smooth muscle function.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Vasodilators